Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts

Transplantation

Volumn 76, Issue 7, 2003, Pages 1029-1036

  Azuma, Haruhito ^a   Wada, Takashi ^b   Gotoh, Rieko ^c   Furuichi, Kengo ^b   Sakai, Norihiko ^b   Yazawa, Koji ^d   Yokoyama, Hitoshi ^b   Katsuoka, Yoji ^a   Takahara, Shiro ^d  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL ADHESION MOLECULES; CYCLOSPORINE; DRUG SYNERGISM; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY TRANSPLANTATION; PYRAZOLES; PYRIDINES; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0142072029     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000090392.56694.06     Document Type: Article

References (22)

1. Graham RM. Cyclosporine: Mechanisms of action and toxicity. Cleve Clin J Med 1994; 61: 308.
2. de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 2000; 35: 333.
3. Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990; 1: 162.
4. Wada T, Furuichi K, Sakai N, et al. Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 2001; 38: 1169.
5. Takahashi S, Keto Y, Fujita T, et al. FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils. J Pharmacol Exp Ther 2001; 296: 48.
6. Kawashima Y, Takeyoshi I, Otani Y, et al. FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen-activated protein kinase. J Heart Lung Transplant 2001; 20: 568.
7. Azuma H, Takahara S, Matsumoto K, et al. Hepatocyte growth factor prevents development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001; 12: 1280.
8. Curtis JJ, Luke RO, Dubovsky E, et al. Cyclosporine in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2: 477.
9. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 1997; 18: 483.
10. Sedmak DD, Orosz CG. The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 1991; 115: 260.
11. Noris M, Remuzzi G. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am J Kidney Dis 1995; 26: 541.
12. Elliot MJ, Finn AH. Interaction between neutrophils and endothelium. Ann Thorac Surg 1993; 56: 1503.
13. Azuma H, Paul LC, Tilney NL. Insights into acute and chronic rejection. Transplant Proc 1996; 28: 2081.
14. Knoflach A, Azuma H, Magee C, et al. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. J Am Soc Nephrol 1999; 10: 1059.
15. Heemann U, Azuma H, Hamar P, et al. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transpl Immunol 1996; 4: 64.
16. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13: 136.
17. Kitada H, Sugitani A, Yamamoto H, et al. Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs. Surgery 2002; 131: 654.
18. Furuichi K, Wada T, Iwata Y, et al. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrol Dial Transplant 2002; 17: 399.
19. Azuma H, Nadeau K, Mackenzie HS, et al. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519.
20. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148.
21. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
22. Terasaki PI, Koyama H, Cecka JM, et al. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 57: 1450.